Mast cell activation syndrome, or MCAS, is an immunological condition where the mast cells in the body release excessive amounts of chemical mediators such as histamine, leading to symptoms such as hives, flushing, rashes, swelling, low blood pressure, dizziness, brain fog, breathing difficulties, and even anaphylaxis
It mirrors the impact we have seen from statins, ace inhibitors, and beta-blockers in similar populations and generally those studies have had a longer treatment duration meaning that semaglutide could be a far superior intervention at the 5 year mark
Discover Glutathione's power
His concern is structural: if compounding eligibility becomes a commercially viable alternative to the full drug approval pathway, pharmaceutical developers will have a financial incentive to bypass Phase III trials entirely
Typically, patients of our weight loss program in Georgetown, Texas who start FDA-approved GLP-1 medications like Ozempic and Wegovy lose an average 15% of their weight when combined with diet and exercise